James P. Cooney
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Immunophenotype and proviral landscape of HTLV-1c infection and pulmonary disease.
Journal: EBioMedicine
Published: February 23, 2026
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses.
Journal: NPJ vaccines
Published: May 26, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.
Journal: Nature communications
Published: December 18, 2024
Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection.
Journal: Nature communications
Published: November 13, 2024
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling.
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling.
Journal: Cell death and differentiation
Published: July 30, 2024
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting.
Journal: Molecular therapy. Methods & clinical development
Published: October 30, 2023
SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 31, 2023
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivo.
Journal: Cell death & disease
Published: February 26, 2023
Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
Journal: Cell reports. Medicine
Published: February 06, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.
Journal: Frontiers in immunology
Published: December 13, 2022
Last Updated: 09/26/2026